Anders Gabrielsen
Overview
Explore the profile of Anders Gabrielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prescott E, Angeras O, Erlinge D, Grove E, Hedman M, Jensen L, et al.
Int J Cardiol
. 2022 Jul;
365:34-40.
PMID: 35842004
Background: Leukotrienes are pro-inflammatory vasoactive lipid mediators implicated in the pathophysiology of atherosclerotic cardiovascular disease. We studied the effect of the 5-lipoxygenase-activating protein inhibitor AZD5718 on leukotriene biosynthesis and coronary...
12.
Knochel J, Nelander K, Heijer M, Lindstedt E, Forsberg G, Whatling C, et al.
Clin Drug Investig
. 2021 Sep;
41(10):895-905.
PMID: 34546534
Background And Objective: AZD5718, a 5-lipoxygenase-activating protein (FLAP) inhibitor, is in clinical development for treatment of coronary artery disease (CAD) and chronic kidney disease (CKD). This study evaluated AZD5718 pharmacokinetics,...
13.
Tengbom J, Cederstrom S, Verouhis D, Bohm F, Eriksson P, Folkersen L, et al.
J Intern Med
. 2021 Jul;
290(5):1061-1070.
PMID: 34237174
Background: The mechanisms underlying rupture of a coronary atherosclerotic plaque and development of myocardial ischemia-reperfusion injury in ST-elevation myocardial infarction (STEMI) remain unresolved. Increased arginase 1 activity leads to reduced...
14.
Darlington P, Gabrielsen A, Cederlund K, Kullberg S, Grunewald J, Eklund A, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2020 Jun;
36(1):11-17.
PMID: 32476931
Aims: Cardiac sarcoidosis (CS) is a potentially life-threatening condition. Early detection of CS is therefore important. The aim of this study was to eludicate the usefulness of different investigations in...
15.
Rafnsson A, Matic L, Lengquist M, Mahdi A, Shemyakin A, Paulsson-Berne G, et al.
Atherosclerosis
. 2019 Oct;
292:215-223.
PMID: 31606133
Background And Aims: Endothelin-1 (ET-1) and arginase are both suggested to be involved in the inflammatory processes and development of endothelial dysfunction in atherosclerosis. However, information regarding the roles of...
16.
Fu E, Andersson Franko M, Obergfell A, Dekker F, Gabrielsen A, Jernberg T, et al.
Am Heart J
. 2019 Aug;
216:20-29.
PMID: 31382219
Background: Persistent, low-grade inflammation likely participates in the pathophysiology of both atherosclerosis and kidney disease. Although high-sensitivity C-reactive protein (hsCRP) predicts future cardiovascular risk in patients with chronic kidney disease...
17.
Carrero J, Andersson Franko M, Obergfell A, Gabrielsen A, Jernberg T
J Am Heart Assoc
. 2019 May;
8(11):e012638.
PMID: 31140334
Background Beyond the controlled setting of trials, scarce information exists on the burden, predictors, and outcomes associated with elevated hs CRP (high-sensitivity C-reactive protein) in "real-world" patients with myocardial infarction...
18.
Zabarovskaja S, Hage C, Gabrielsen A, Mellbin L, Lund L
Heart Lung Circ
. 2016 Aug;
26(2):143-149.
PMID: 27523461
Background: Heart failure (HF) is associated with pathological activation of arginine vasopressin, measured in plasma by the pre-hormone fragment copeptin. We hypothesised that copeptin is elevated and associated with worse...
19.
Wei T, Folkersen L, Ehrenborg E, Gabrielsen A
Biosci Rep
. 2016 May;
36(3).
PMID: 27190129
Easily accessible biomarkers are needed to diagnose cardiovascular disease precisely-particularly, to distinguish between disease subtypes that are encountered in clinical practice. Per the hypothesis that plasma miRNA is valuable for...
20.
Zabarovskaja S, Hage C, Linde C, Daubert J, Donal E, Gabrielsen A, et al.
Int J Cardiol
. 2015 Apr;
189:6-11.
PMID: 25885866
Background/objectives: In heart failure (HF), activation of brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP) and adrenomedullin (ADM) is adaptive. The activation of these peptides in relation to different HF...